Heart Failure Update banner indicating registration is now open.

Workshop Descriptions




Friday, May 12th 1:55 p.m. - 2:40 p.m. 

Ischemic CMP: To revascularize or not? 
Lisa Mielniczuk, MD

Numerous factors influence the decision to revascularize patients with ischemic cardiomyopathy. This interactive case-based workshop will draw on evidence from recent clinical trials to paint the picture of scenarios where surgical revascularization should be a preferred approach or when other strategies should be favoured.

Nonischemic CMP: Tips and Tricks for Identification of Uncommon Cardiomyopathies
Robert Miler, MD

This workshop will address some practical strategies for the initial work-up and diagnosis of nonischemic cardiomyopathy, which can result from a wide range of potential etiologies, some of which are uncommon and not yet fully characterized.

CCS/CHFS HF Guidelines Refresher
Anique Ducharme, MD; Rodolfo Pike, NP

Two years ago, the CCS/CHFS updated their comprehensive recommendations for the management of HFrEF and defined a new standard of pharmacologic care that incorporates four key drug classes for most patients. This practical workshop will offer participants tips to support the integration of prioritized pharmacologic, nonpharmacologic and invasive therapies in patients with HFrEF.

Pulmonary Hypertension: When it's the Heart and When it's Not
Susanna Mak, MD

Pulmonary hypertension (PH) encompasses a heterogeneous group of disorders that include cardiac and noncardiac etiologies, making accurate diagnosis a clinical challenge. This workshop will address factors that should lead to a high index of suspicion of cardiac causes of PH and investigations to confirm the diagnosis and underlying etiology to guide the implementation of appropriate management strategies.


Saturday, May 13th 11:55 a.m. - 12:20 p.m.

Novel Methods for Decongesting in a Pinch
Stephanie Poon, MD

Volume overload is one of the commonest reasons for hospitalization. Although diuretics are a mainstay approach for decongestion, the development of diuretic resistance is not uncommon and presents a challenging scenario. This case-based workshop will address the role of standard and novel decongestion strategies and situations where they can be appropriately applied.

Atrial Fibrillation and HF: Pros and Cons of Ablation
Ratika Parkash, MD

There is mounting evidence that ablation for atrial fibrillation offers meaningful clinical benefit in patients with HFrEF. This workshop will summarize some of the latest research and recommendations for the appropriate selection of patients for ablative strategies.  

Virtual Nursing for HF Clinics: Connecting the Old and New Worlds of Clinical Practice
Wynne Chiu, MSN, RN; Linda Wick, MSN, CNP, CHFN 

The pandemic ushered in a new era of virtual care to ensure the continuation of health service provision. This workshop will address some of the learnings that can be applied to virtual nursing care in HF clinics with a focus on the feasibility and safety of virtual medication optimization.

Update on Cardiac Amyloidosis
Margot Davis, MD

Amyloidosis continues to be a hot topic of clinical research and innovation. This year’s HF Update workshop devoted to cardiac amyloid aims to improve clinician competencies in the workup and treatment of cardiac amyloidosis and puts a spotlight on current and pipeline treatments for cardiac ATTR.


Follow @CanHFSociety Along on Twitter